Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74

被引:50
作者
Rosenkilde, MM [1 ]
Kledal, TN [1 ]
Holst, PJ [1 ]
Schwartz, TW [1 ]
机构
[1] Univ Copenhagen, Panum Inst 18 6 12, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark
关键词
D O I
10.1074/jbc.M003800200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Open reading frame 74 (ORF74) encoded by human herpesvirus 8 is a highly constitutively active seven transmembrane (7TM) receptor stimulated by angiogenic chemokines, e.g, growth-related oncogene-cv, and inhibited by angiostatic chemokines e.g, interferon-gamma-inducible protein. Transgenic mice expressing ORF74 under control of the CD2 promoter develop highly vascularized Kaposi's sarcoma-like tumors. Through targeted mutagenesis we here create three distinct phenotypes of ORF74: a receptor with normal, high constitutive signaling through the phospholipase C pathway but deprived of binding and action of chemokines obtained through deletion of 22 amino acids from the N-terminal extension; an ORF74 with high constitutive activity but with selective elimination of stimulatory regulation by angiogenic chemokines obtained through substitution of basic residues at the extracellular ends of TRI-V or TM-VI; and an ORF74 lacking constitutive activity but with preserved ability to be stimulated by agonist chemokines obtained through introduction of an Asp residue on the hydrophobic, presumed membrane-exposed face of TM-II, It is concluded that careful molecular dissection can selectively eliminate either agonist or inverse agonist modulation as well as high constitutive activity of the virally encoded oncogene ORF74 and that these mutant forms presumably can be used in transgenic animals to identify the molecular mechanism of its transforming activity.
引用
收藏
页码:26309 / 26315
页数:7
相关论文
共 44 条
  • [1] AHUJA SK, 1993, J BIOL CHEM, V268, P20691
  • [2] AHUJA SK, 1999, CHEMOKINES DIS
  • [3] Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation
    Arvanitakis, L
    GerasRaaka, E
    Varma, A
    Gershengorn, MC
    Cesarman, E
    [J]. NATURE, 1997, 385 (6614) : 347 - 350
  • [4] G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
    Bais, C
    Santomasso, B
    Coso, O
    Arvanitakis, L
    Raaka, EG
    Gutkind, JS
    Asch, AS
    Cesarman, E
    Gerhengorn, MC
    Mesri, EA
    [J]. NATURE, 1998, 391 (6662) : 86 - 89
  • [5] THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS
    BALDWIN, JM
    [J]. EMBO JOURNAL, 1993, 12 (04) : 1693 - 1703
  • [6] The conformational change responsible for AT(1) receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII
    Balmforth, AJ
    Lee, AJ
    Warburton, P
    Donnelly, D
    Ball, SG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) : 4245 - 4251
  • [7] CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES
    BERRIDGE, MJ
    DAWSON, RMC
    DOWNES, CP
    HESLOP, JP
    IRVINE, RF
    [J]. BIOCHEMICAL JOURNAL, 1983, 212 (02) : 473 - 482
  • [8] Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein
    Blanpain, C
    Doranz, BJ
    Vakili, J
    Rucker, J
    Govaerts, C
    Baik, SSW
    Lorthioir, O
    Migeotte, I
    Libert, F
    Baleux, F
    Vassart, G
    Doms, RW
    Parmentier, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 34719 - 34727
  • [9] Burger M, 1999, J IMMUNOL, V163, P2017
  • [10] Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma
    Cesarman, E
    Nador, RG
    Bai, F
    Bohenzky, RA
    Russo, JJ
    Moore, PS
    Chang, Y
    Knowles, DM
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (11) : 8218 - 8223